← Back to Patent Explorer
US5945033A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for making non-crosslinked protein particles for therapeutic and diagnostic use

Assignee: PTL PHILANTHROPY LLC
•
Filing: 1996-11-12
•
Granted: 1999-08-31
•
Expires: 2016-11-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Albumin particles in the nanometer and micrometer size range in an aqueous suspension are rendered stable against resolubilization without the aid of a crosslinking agent and without denaturation, by the incorporation of hemoglobin in the particle composition. Particles which are primarily hemoglobin in the nanometer and micrometer size range in an aqueous suspension are rendered stable against aggregation by the incorporation of either albumin, surface active agents or gelatin.

Inventors

  • 👤 Richard C. K. Yen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:16
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/51; A61K9/5107; A61K9/513; A61K9/5169; A61K47/00; A61K47/50; A61K47/69; A61K47/6905; A61K47/6907; A61K47/6921; A61K47/6927; A61K47/6929; A61K9/14; A61K9/16; A61K9/1605; A61K9/1611; A61K9/1617; A61K9/1629; A61K9/1658; A61K9/5192; B; B82; B82Y; B82Y5/00; Y; Y10; Y10S; Y10S977/00; Y10S977/70; Y10S977/773; Y10S977/788; Y10S977/797; Y10S977/902; Y10S977/904; Y10S977/905; Y10S977/927; Y10S977/93; Y10T; Y10T428/00; Y10T428/29; Y10T428/2982; Y10T428/2984; Y10T428/2989

Claims Analysis

Total Claims: 13
Claim 1
Independent Claim 88 words
A method for the preparation of an aqueous suspension of monodisperse particles of non-crosslinked, non-denatured albumin, having a size range of from about 50 to about 5000 nanometers in diameter and stable against dissolving upon dilution with an alcohol-free aqueous dilution medium, said method comprising: (a) forming an aqueous solution containing albumin and hemoglobin; and (b) treating said aqueous solution with an alcohol in an amount sufficient to cause said aqueous solution to become turbid; wherein steps (a) and (b) are performed without crosslinking said albumin and hemoglobin.
Claim 2
Independent Claim 88 words
A method for the preparation of an aqueous suspension of monodisperse particles of non-crosslinked, non-denatured albumin, having a size range of from about 50 to about 5000 nanometers in diameter and stable against dissolving upon dilution with an alcohol-free aqueous dilution medium, said method comprising: (a) forming an aqueous solution containing albumin and hemoglobin; and (b) treating said aqueous solution with an alcohol in an amount sufficient to cause said aqueous solution to become turbid; wherein steps (a) and (b) are performed without crosslinking said albumin and hemoglobin.
Claim 3
Dependent Claim 33 words
A method in accordance with claim 1 in which said hemoglobin of step (a) is from about 1% to about 70% by weight relative to the total of said albumin and said hemoglobin.
Claim 4
Dependent Claim 33 words
A method in accordance with claim 1 in which said hemoglobin of step (a) is from about 1% to about 30% by weight relative to the total of said albumin and said hemoglobin.
Claim 5
Dependent Claim 16 words
A method in accordance with claim 1 in which said alcohol is a lower alkyl alcohol.
Claim 6
Dependent Claim 26 words
A method in accordance with claim 1 in which said alcohol is a member selected from the group consisting of methanol, ethanol, n-propanol, isopropanol and n-butanol.
Claim 7
Dependent Claim 23 words
A method in accordance with claim 1 in which said alcohol is a member selected from the group consisting of ethanol and n-butanol.
Claim 8
Dependent Claim 22 words
A method in accordance with claim 1 in which step (a) further comprises including in said aqueous solution an anionic water-soluble surfactant.
Claim 9
Dependent Claim 29 words
A method in accordance with claim 7 in which said anionic water-soluble surfactant is included at a concentration of at least about 0.1 g per liter of said suspension.
Claim 10
Dependent Claim 46 words
A method in accordance with claim 7 in which said anionic water-soluble surfactant is included at a concentration of from about 0.5 g to about 5 g per liter of said suspension, and said particles comprise at least about 15 g per liter of said suspension.
Claim 11
Dependent Claim 62 words
A method in accordance with claim 7 in which said anionic water-soluble surfactant is a member selected from the group consisting of sodium lauryl sulfate and sodium tetradecylsulfate, and is included at a concentration of from about 0.5 g to about 5 g per liter of said suspension, and said particles comprise at least about 15 g per liter of said suspension.
Claim 12
Dependent Claim 14 words
A method in accordance with claim 1 in which said hemoglobin is human hemoglobin.
Claim 13
Dependent Claim 15 words
A method in accordance with claim 1 in which said albumin is human serum albumin.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-08-30 2003-03-01 2003-08-31 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-08-30 2007-03-01 2007-08-31 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-08-30 2011-03-01 2011-08-31 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag